Co-Overexpression of TWIST1-CSF1 Is a Common Event in Metastatic Oral Cancer and Drives Biologically Aggressive Phenotype.

CSF1 EMT TWIST1 genomic metastasis oral squamous cell carcinoma tumor invasion tumor-associated macrophages

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
05 Jan 2021
Historique:
received: 11 11 2020
revised: 11 12 2020
accepted: 18 12 2020
entrez: 20 1 2021
pubmed: 21 1 2021
medline: 21 1 2021
Statut: epublish

Résumé

Invasive oral squamous cell carcinoma (OSCC) is often ulcerated and heavily infiltrated by pro-inflammatory cells. We conducted a genome-wide profiling of tissues from OSCC patients (early versus advanced stages) with 10 years follow-up. Co-amplification and co-overexpression of

Identifiants

pubmed: 33466385
pii: cancers13010153
doi: 10.3390/cancers13010153
pmc: PMC7795342
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Fundação de Amparo à Pesquisa do Estado de São Paulo
ID : 06/61039-8 and CEPID/FAPESP 98/14335
Organisme : National Institute of Science and Technology in Oncogenomics
ID : INCITO/FAPESP 2008/57887-9
Organisme : Conselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq
ID : 573589/08-9
Organisme : Quebec Breast Cancer Foundation
ID : #MAJ
Organisme : Global Affair/DFATD
ID : 249584
Organisme : Brazil-Canada
ID : #249569
Organisme : RSBO
ID : #80596
Organisme : NCOHR
ID : #SDS

Références

Front Pharmacol. 2012 Jul 30;3:149
pubmed: 23060791
Nat Med. 1998 Jul;4(7):844-7
pubmed: 9662379
Cell. 2004 Aug 6;118(3):277-9
pubmed: 15294153
Mol Cancer. 2011 Sep 22;10:117
pubmed: 21939504
Lancet. 2019 Jan 12;393(10167):156-167
pubmed: 30509740
Cancer Res. 2014 Mar 15;74(6):1694-704
pubmed: 24599131
Clin Cancer Res. 1998 Aug;4(8):1851-6
pubmed: 9717811
N Engl J Med. 2010 Mar 11;362(10):875-85
pubmed: 20220182
J Natl Cancer Inst. 2014 May 29;106(6):dju124
pubmed: 24875653
J Immunol. 2010 Jan 15;184(2):702-12
pubmed: 20018620
Curr Opin Oncol. 2009 May;21(3):194-200
pubmed: 19363341
Br J Cancer. 2014 May 13;110(10):2560-8
pubmed: 24691423
Oncogene. 2015 May 21;34(21):2721-31
pubmed: 25088194
Cancer. 2014 Feb 1;120(3):352-62
pubmed: 24150986
Cancer Res. 2014 Sep 15;74(18):5057-69
pubmed: 25082815
Cell. 2010 Apr 2;141(1):39-51
pubmed: 20371344
Immunol Lett. 2009 Apr 27;123(2):97-102
pubmed: 19428556
Oncogene. 2002 Apr 18;21(17):2634-40
pubmed: 11965536
J Pathol. 2013 Jul;230(3):310-21
pubmed: 23520016
Cancer Res. 2010 Jun 15;70(12):4840-9
pubmed: 20501839
Am J Pathol. 2011 Oct;179(4):1827-38
pubmed: 21854747
J Otolaryngol. 2006 Jun;35(3):157-66
pubmed: 16929991
Cancer Res. 2011 Feb 15;71(4):1325-33
pubmed: 21169414
Ann N Y Acad Sci. 2004 Apr;1014:58-66
pubmed: 15153420
Neoplasia. 2006 Nov;8(11):925-32
pubmed: 17132224
Stem Cells. 1994;12 Suppl 1:15-24; discussion 25
pubmed: 7696959
PLoS One. 2011 Mar 28;6(3):e18023
pubmed: 21464926
Clin Cancer Res. 2014 Dec 1;20(23):6212-22
pubmed: 25271081
Oncogene. 2014 Aug 21;33(34):4359-64
pubmed: 24362524
Curr Opin Immunol. 2006 Feb;18(1):39-48
pubmed: 16337366
Oral Oncol. 2019 Jan;88:131-136
pubmed: 30616783
PLoS One. 2011;6(12):e29758
pubmed: 22242143
Cancer Res. 2013 Jan 15;73(2):662-71
pubmed: 23329645
Clin Transl Med. 2020 Nov;10(7):e209
pubmed: 33252865
Cancer Res. 2010 Feb 15;70(4):1323-33
pubmed: 20145133
J Exp Med. 2010 Oct 25;207(11):2421-37
pubmed: 20937704
Lab Invest. 2014 Apr;94(4):371-81
pubmed: 24468794
Oncotarget. 2015 Sep 8;6(26):21950-63
pubmed: 26110570
Cancer Microenviron. 2014 Dec;7(3):153-60
pubmed: 25337680
Cancer Lett. 2013 May 10;332(1):3-10
pubmed: 23348699
Nucleic Acids Res. 2001 May 1;29(9):e45
pubmed: 11328886
Arch Otolaryngol Head Neck Surg. 2007 Sep;133(9):910-8
pubmed: 17875858
BMC Cancer. 2012 Jan 24;12:35
pubmed: 22273460
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Clin Cancer Res. 2015 Feb 15;21(4):687-92
pubmed: 25501578
Cancer Res. 2007 Oct 1;67(19):9066-76
pubmed: 17909010
EMBO Mol Med. 2014 Sep 11;6(10):1279-93
pubmed: 25214461
Cancer Res. 2009 Dec 15;69(24):9498-506
pubmed: 19934330
Development. 2001 Aug;128(16):3145-59
pubmed: 11688563
Oncogene. 2012 Mar 15;31(11):1459-67
pubmed: 21822305
PLoS One. 2010 Oct 26;5(10):e13587
pubmed: 21049007
BMC Mol Biol. 2010 Sep 21;11:74
pubmed: 20858237

Auteurs

Sabrina Daniela da Silva (SD)

Department of Otolaryngology Head and Neck Surgery, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
Segal Cancer Centre and Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Departments of Medicine, Oncology, and Pharmacology and Therapeutics, Faculty of Medicine, McGill University, Montreal, QC H3T 1E2, Canada.

Fabio Albuquerque Marchi (FA)

Department of Head and Neck Surgery and Otorhinolaryngology, AC Camargo Cancer Center and National Institute of Science and Technology on Oncogenomics (INCITO), São Paulo 01509-010, Brazil.

Jie Su (J)

Segal Cancer Centre and Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Departments of Medicine, Oncology, and Pharmacology and Therapeutics, Faculty of Medicine, McGill University, Montreal, QC H3T 1E2, Canada.

Long Yang (L)

School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.

Ludmila Valverde (L)

Department of Otolaryngology Head and Neck Surgery, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, QC H3T 1E2, Canada.

Jessica Hier (J)

Department of Otolaryngology Head and Neck Surgery, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, QC H3T 1E2, Canada.

Krikor Bijian (K)

Segal Cancer Centre and Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Departments of Medicine, Oncology, and Pharmacology and Therapeutics, Faculty of Medicine, McGill University, Montreal, QC H3T 1E2, Canada.

Michael Hier (M)

Department of Otolaryngology Head and Neck Surgery, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, QC H3T 1E2, Canada.

Alex Mlynarek (A)

Department of Otolaryngology Head and Neck Surgery, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, QC H3T 1E2, Canada.

Luiz Paulo Kowalski (LP)

Department of Head and Neck Surgery and Otorhinolaryngology, AC Camargo Cancer Center and National Institute of Science and Technology on Oncogenomics (INCITO), São Paulo 01509-010, Brazil.

Moulay A Alaoui-Jamali (MA)

Segal Cancer Centre and Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Departments of Medicine, Oncology, and Pharmacology and Therapeutics, Faculty of Medicine, McGill University, Montreal, QC H3T 1E2, Canada.

Classifications MeSH